Amwill Healthcare’s shares will debut on the BSE SME platform with an IPO price of Rs 111 each. The IPO saw moderate investor interest, driven by institutional support. Amwill focuses on derma-cosmetic products, outsourcing manufacturing and distribution to third parties. India’s $14 billion beauty industry is growing rapidly due to online sales and a trend toward personalised products.
RBI eases restrictions on cash credit accounts, eases current account norms
The Reserve Bank of India has lifted all restrictions on banks opening and maintaining cash credit accounts, offering greater flexibility for short-term working capital loans.